person

Charikleia N.

Country
Greece
Department
Intensive Care Unit

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 15 partner sites.

Specializations

Cardiovascular Disease & Myocardial Infarction

The investigator concentrates on the pathophysiology and risk mitigation of Acute myocardial infarction and broader atherosclerotic disease.

  • Acute myocardial infarction
  • Atherosclerotic cardiovascular disease
  • Major adverse cardiovascular events
  • Lipoprotein(a) reduction
  • Systemic inflammation

Research aims to integrate anti‑inflammatory strategies with lipid‑targeted therapy to lower event rates in high‑risk patients.

Heart Failure Phenotypes & Renal Interaction

Efforts focus on distinct Heart failure subtypes and their interplay with kidney dysfunction.

  • Heart failure with reduced ejection fraction
  • HFpEF/HFmrEF
  • Chronic kidney disease
  • Cardiorenal syndrome
  • Inflammation‑driven heart failure

Studies evaluate combined therapeutic approaches that address both cardiac performance and renal protection.

Atrial Fibrillation & Anticoagulation Strategies

Work in this area targets rhythm management and stroke prevention in patients with Atrial fibrillation.

  • Atrial fibrillation
  • Stroke prevention
  • Factor Xa inhibitor reversal
  • Non‑vitamin K antagonist oral anticoagulants
  • Cardioversion techniques

Clinical focus includes optimizing anticoagulant safety while maintaining efficacy for embolic protection.

Dermatologic Immune‑Mediated Disorders

The investigator explores biologic and topical interventions for chronic pruritic skin diseases.

  • Atopic dermatitis
  • Prurigo nodularis
  • Neurodermatitis
  • Lichen simplex chronicus
  • IL‑4/IL‑13 blockade

Research seeks to diminish itch severity and improve skin barrier function through targeted immune modulation.

Critical Care Pulmonary & Infectious Complications

In the intensive care setting, attention is given to severe respiratory infections and thrombotic risk.

  • Hospital‑acquired pneumonia
  • Ventilator‑associated pneumonia
  • Venous thromboembolism
  • Antimicrobial stewardship
  • Critical care infection control

Studies assess preventive and therapeutic measures to reduce morbidity in mechanically ventilated patients.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.